Skip to main content
. 2023 Jun 21;11:e15536. doi: 10.7717/peerj.15536

Table 1. Demographic and clinical characteristics of the Han population.

Continuous variables are expressed as mean ± SD, or median (25th, 75th percentiles). Categorical variables are expressed as number and percentage. The P value of the continuous variables was calculated by the independent-sample t-test. The P value of the categorical variables was calculated by χ2 test.

Variables Total Cohort (n = 1,326) T2DM (n = 331) Control (n = 995) P value
Age (years) 60.68 ± 11.14 61.47 ± 10.92 60.42 ± 11.18 0.140
Male, n (%) 853 (64.3%) 221 (66.8%) 632 (63.5%) 0.290
Smoking, n (%) 508 (54.8%) 116 (47.9%) 392 (57.2%) 0.013
Drinking, n (%) 233 (25.4%) 53 (22.2%) 180 (26.5%) 0.196
Hypertension, n (%) 339 (51.9%) 125 (61.3%) 214 (47.7%) 0.001
BMI (kg/m2) 25.56 ± 3.40 25.90 ± 3.20 25.45 ± 3.45 0.194
SBP (mmHg) 142.99 ± 31.50 149.68 ± 33.16 140.77 ± 30.63 <0.001
DBP (mmHg) 89.32 ± 45.89 90.04 ± 19.24 89.08 ± 51.81 0.791
HbA1c, % 5.58 (5.28, 6.65) 7.84 (7.46, 8.25) 5.44 (5.19, 5.66) <0.001
FBS (mmol/L) 6.03 ± 2.56 9.12 ± 2.12 4.99 ± 0.80 <0.001
TG (mmol/L) 1.88 ± 1.81 2.04 ± 1.35 1.83 ± 1.94 0.065
TC (mmol/L) 4.10 ± 1.08 4.22 ± 1.18 4.06 ± 1.04 0.025
HDL-C (mmol/L) 1.09 ± 0.43 1.04 ± 0.32 1.11 ± 0.46 0.005
LDL-C (mmol/L) 2.55 ± 0.87 2.69 ± 0.92 2.50 ± 0.85 0.001
Uric acid (µmol/L) 305.94 ± 103.71 281.62 ± 105.83 314.02 ± 101.76 <0.001
BUN (mmol/L) 6.28 ± 7.72 6.20 ± 5.47 6.30 ± 8.33 0.833
Cr (mmol/L) 74.37 ± 40.34 74.17 ± 38.69 74.43 ± 40.88 0.920
LVEF, % 63 (60, 66) 62 (57, 65) 63 (60, 67) 0.002
Diabetic complications
CAD 82(24.8%)
peripheral neuropathy 61(18.4%)
diabetic retinopathy 51(15.4%)
Diabetes Medication
Metformin 178(53.8%)
acarbose 71(21.5%)
Glinides 33(9.97%)
insulin 152(45.9%)

Notes.

BMI
body mass index
SBP
systolic blood pressure
DBP
diastolic blood pressure
FBS
fasting plasma glucose
TG
triglyceride
TC
total cholesterol
HDL-C
high-density lipoprotein cholesterol
LDL-C
low-density lipoprotein cholesterol
BUN
blood urea nitrogen
Cr
creatinine
LVEF
left ventricular ejection fractions
CAD
coronary atherosclerotic heart disease

The bold styling indicates that the P value is less than 0.05, and there is a significant difference between the case group and the control group.